Evidence map›Paper›PMID 35368455›Full record

ArticleMolecular imaging2022

The Potential Prognostic Value of Dual-Imaging PET Parameters Based on

Jiale Hou, Tingting Long, Yi Yang, Dengming Chen, Shuo Hu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecular imaging, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Dual-tracerFrontiers in endocrinology · 2025
    Pooled it
  2. Observational
  3. Frontiers in endocrinology · 2024
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jiale HouDepartment of Nuclear Medicine, XiangYa Hospital, Central South University, No. 87 XiangYa Road, Changsha, Hunan Province, China.
Tingting LongDepartment of Nuclear Medicine, XiangYa Hospital, Central South University, No. 87 XiangYa Road, Changsha, Hunan Province, China.
Yi YangDepartment of Nuclear Medicine, XiangYa Hospital, Central South University, No. 87 XiangYa Road, Changsha, Hunan Province, China.
Dengming ChenDepartment of Nuclear Medicine, XiangYa Hospital, Central South University, No. 87 XiangYa Road, Changsha, Hunan Province, China.
Shuo HuDepartment of Nuclear Medicine, XiangYa Hospital, Central South University, No. 87 XiangYa Road, Changsha, Hunan Province, China.ORCID 0000-0003-0998-8943

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To identify parameters based on dual-imaging Materials and Methods: Sixty-six patients (age: mean ± standard deviation (SD): 51.8 ± 11.8 years) who underwent both Results: In the univariate survival analyses of clinical information, PFS was significantly associated with age (>45.5 vs ≤45.5, years, Conclusion: The NETPET grade is a potential noninvasive prognostic biomarker for NENs.

Indexed as

Fluorodeoxyglucose F18NeoplasmsHumansMiddle AgedPositron-Emission TomographyPositron Emission Tomography Computed TomographyPrognosisRadiopharmaceuticalsRetrospective StudiesFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID35368455
PMCPMC8959579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.